In addition to the above-mentioned KDM1A inhibitors, many potent KDM1A inhibitors with IC50 values in the nanomolar range (9.8–77 nM) have been found with the ability to inhibit the proliferation of MLL-rearranged leukemia cells [155]. Here, KMT2A is linked to leukemia.